Published in Biomaterials on December 17, 2010
Synergetic Targeted Delivery of Sleeping-Beauty Transposon System to Mesenchymal Stem Cells Using LPD Nanoparticles Modified with a Phage-Displayed Targeting Peptide. Adv Funct Mater (2013) 0.95
DNA transposon-based gene vehicles - scenes from an evolutionary drive. J Biomed Sci (2013) 0.89
Degradable copolymer based on amphiphilic N-octyl-N-quatenary chitosan and low-molecular weight polyethylenimine for gene delivery. Int J Nanomedicine (2012) 0.85
Coupling of a bifunctional peptide R13 to OTMCS-PEI copolymer as a gene vector increases transfection efficiency and tumor targeting. Int J Nanomedicine (2014) 0.79
Efficient sleeping beauty DNA transposition from DNA minicircles. Mol Ther Nucleic Acids (2013) 0.79
Near-infrared optical imaging of nucleic acid nanocarriers in vivo. Methods Mol Biol (2013) 0.75
A Biodegradable Polyethylenimine-Based Vector Modified by Trifunctional Peptide R18 for Enhancing Gene Transfection Efficiency In Vivo. PLoS One (2016) 0.75
Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res (2010) 3.18
Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res (2008) 2.43
Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia (2005) 2.04
EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res (2010) 1.95
Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res (2005) 1.86
Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration. Am J Ophthalmol (2005) 1.59
The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells. J Proteome Res (2009) 1.58
Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc (2007) 1.57
Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan. PLoS One (2012) 1.53
Concern Dual regeneration of muscle and nerve by intravenous administration of human amniotic fluid-derived mesenchymal stem cells regulated by stromal cell-derived factor-1α in a sciatic nerve injury model. J Neurosurg (2012) 1.51
Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells (2005) 1.39
The multiple roles of amphiregulin in human cancer. Biochim Biophys Acta (2011) 1.39
Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res (2010) 1.39
Antitumor and antimetastatic activity of IL-23. J Immunol (2003) 1.38
Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med (2002) 1.36
Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem Int Ed Engl (2011) 1.36
Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. J Am Chem Soc (2004) 1.32
Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy. Clin Cancer Res (2009) 1.25
Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res (2003) 1.21
Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol (2006) 1.20
A mouse model of blast-induced mild traumatic brain injury. Exp Neurol (2011) 1.20
p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene (2003) 1.20
In vivo mice lung tumor follow-up with fluorescence diffuse optical tomography. J Biomed Opt (2008) 1.19
CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells. Int J Cancer (2005) 1.18
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem (2002) 1.18
In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. Mol Cancer (2007) 1.17
HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO J (2004) 1.17
Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res (2005) 1.17
Curcumin provides neuroprotection after spinal cord injury. J Surg Res (2009) 1.16
ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion. Cancer Res (2012) 1.16
Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers. EMBO Mol Med (2013) 1.16
Urbanization and stroke prevalence in Taiwan: analysis of a nationwide survey. J Urban Health (2007) 1.16
Household out-of-pocket medical expenditures and National Health Insurance in Taiwan: income and regional inequality. BMC Health Serv Res (2005) 1.16
Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution. Adv Drug Deliv Rev (2011) 1.15
Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma. Biomaterials (2009) 1.14
Nitric oxide from both exogenous and endogenous sources activates mitochondria-dependent events and induces insults to human chondrocytes. J Cell Biochem (2007) 1.13
Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines. J Biol Chem (2002) 1.13
In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes. Arthritis Rheum (2009) 1.13
Using health smart cards to check drug allergy history: the perspective from Taiwan's experiences. J Med Syst (2009) 1.12
Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4. Mol Imaging (2006) 1.12
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest (2010) 1.11
MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells. Arch Toxicol (2012) 1.10
Burnout, job satisfaction, and medical malpractice among physicians. Int J Med Sci (2013) 1.09
Comparisons of the brief form of the World Health Organization Quality of Life and Short Form-36 for persons with spinal cord injuries. Am J Phys Med Rehabil (2007) 1.09
Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. Mol Ther (2009) 1.09
Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. Small (2009) 1.08
Risk of epilepsy after traumatic brain injury: a retrospective population-based cohort study. J Neurol Neurosurg Psychiatry (2012) 1.08
The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis. Biomaterials (2011) 1.06
Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res (2009) 1.06
Targeting cancer stem cells: emerging role of Nanog transcription factor. Onco Targets Ther (2013) 1.06
Role of angiogenic and non-angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression. J Oral Pathol Med (2004) 1.06
The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer. Stem Cells (2013) 1.05
Zerumbone suppresses IKKα, Akt, and FOXO1 activation, resulting in apoptosis of GBM 8401 cells. J Biomed Sci (2012) 1.04
CCM1-ICAP-1 complex controls β1 integrin-dependent endothelial contractility and fibronectin remodeling. J Cell Biol (2013) 1.03
MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation. J Biol Chem (2009) 1.03
Effectiveness of different types of motorcycle helmets and effects of their improper use on head injuries. Int J Epidemiol (2011) 1.03
Attenuating experimental spinal cord injury by hyperbaric oxygen: stimulating production of vasculoendothelial and glial cell line-derived neurotrophic growth factors and interleukin-10. J Neurotrauma (2010) 1.02
Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease. Antimicrob Agents Chemother (2009) 1.02
Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology (2005) 1.02
Implication of transforming growth factor-beta1 in Chagas disease myocardiopathy. J Infect Dis (2002) 1.02
Regression analysis for the sorption isotherms of basic dyes on sugarcane dust. Bioresour Technol (2005) 1.01
Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials (2011) 1.01
Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma. J Pathol (2011) 1.01
Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation (2002) 1.00
Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season. PLoS One (2013) 1.00
Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur J Pharm Biopharm (2010) 1.00
Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis (2004) 1.00
Hirayama disease. J Neurosurg Spine (2010) 0.99
Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands. Org Biomol Chem (2006) 0.99
Autophagy is activated in injured neurons and inhibited by methylprednisolone after experimental spinal cord injury. Spine (Phila Pa 1976) (2012) 0.98
Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways. Cell Signal (2005) 0.98
Two non-homologous brain diseases-related genes, SERPINI1 and PDCD10, are tightly linked by an asymmetric bidirectional promoter in an evolutionarily conserved manner. BMC Mol Biol (2007) 0.98
Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication. J Virol (2004) 0.97
Multifaceted effects of rapamycin on functional recovery after spinal cord injury in rats through autophagy promotion, anti-inflammation, and neuroprotection. J Surg Res (2012) 0.97
The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism. Int J Cancer (2013) 0.97
Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol Pharmacol (2003) 0.96
Prevention and repair of circulatory shock and cerebral ischemia/injury by various agents in experimental heatstroke. Curr Med Chem (2006) 0.96
New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors. Mol Ther (2005) 0.96
Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy. Cytokine Growth Factor Rev (2008) 0.95
Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells. J Cereb Blood Flow Metab (2010) 0.95
The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis. Stem Cell Res Ther (2013) 0.95
Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression. Biochem Biophys Res Commun (2003) 0.94
Rac1 regulates peptidoglycan-induced nuclear factor-kappaB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages by activating the phosphatidylinositol 3-kinase/Akt pathway. Mol Immunol (2008) 0.94
Congenital midline nasal mass: cases series and review of the literature. Turk J Pediatr (2011) 0.93
In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4). Mol Imaging (2007) 0.93
Mass screening of suspected febrile patients with remote-sensing infrared thermography: alarm temperature and optimal distance. J Formos Med Assoc (2008) 0.92
Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells. J Biol Chem (2005) 0.92
Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion. Am J Pathol (2005) 0.92
Gene transfer of insulin-like growth factor-I providing neuroprotection after spinal cord injury in rats. J Neurosurg Spine (2007) 0.92
The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging. BMC Cancer (2010) 0.91
Working memory in patients with mild traumatic brain injury: functional MR imaging analysis. Radiology (2012) 0.91